-
Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory
Biotech Newswire
April 26, 2024
Biobatteries use enzymes to generate electricity from the breakdown of complex fuels, such as carbohydrates, fatty acids and alcohols.
-
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery
Biotech Newswire
April 10, 2024
TheWell Bioscience is a pioneer in the field of animal-free hydrogels and bioinks, critical components for the creation of 3D biomimicking platforms.
-
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
Biotech Newswire
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.
-
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
Biotech Newswire
April 01, 2024
ProBioGen’s MVA CR19vector will be used to deliver the three HF vaccine antigens.
-
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
PharmaSources
April 01, 2024
ICP-189 is a potent and selective oral allosteric inhibitor of SHP2, developed by InnoCare for the treatment of solid tumors as a single agent and/or in combination with other antitumor agents.
-
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
PharmaSources
March 21, 2024
Recognition reinforces Avantor's commitment to innovation and leadership for biopharma advancement.
-
Engineering the Cure: Advancement in Molecular Biology is building better drugs
Shruti Talashi
March 18, 2024
Molecular biology holds the capacity to impact nearly every facet of drug research,
development, and utilization.
-
Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment
Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
-
ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease Using GlymaxX Technology
Biotech Newswire
March 15, 2024
This collaborative effort will leverage ProBioGen's cutting-edge GlymaxX® technology to enhance the therapeutic potential of the antibody by adjusting the afucosylation levels.
-
ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network
Biotech Newswire
March 13, 2024
The Ginkgo Technology Network brings together a diverse array of partners, spanning AI, genetic medicines, biologics, and manufacturing.